Bafna Pharmaceuticals Limited (BAFNAPH)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹268.20+12.62%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹42 cr

Revenue YoY

+8.1%

Net profit

₹3 cr

Profit YoY

+109.7%

Net margin

6.5%

Market cap

₹634 cr

P/E

57.3

Forward P/E

0.0

P/B

6.47

Book value

₹40.57

EPS (TTM)

₹4.68

52-week high

₹268.20

52-week low

₹78.18

50-day MA

₹192.91

200-day MA

₹149.08

Beta

0.08

Promoters

90.22%

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Bafna Pharmaceuticals Limited — free to start.

Data updated 2026-08-05.